Abstract Details

Title Racial Disparities in Stroke Mortality in the United States 2000-2009

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P05 - (-)

Poster/Presentation
Number 212

Objective

Background BACKGROUND: There has been reduction in stroke related mortality among all racial groups. To test this hypothesis we conducted this study -that the racial disparities in stroke mortality have declined in the last decade due to increased awareness and recognition.

Design/Methods DESIGN/METHODS: Analysis of the U.S. multiple-cause-of-death files for 2000 to 2009 was used. Decedents with stroke (defined by ICD-10 code I60-I64) as underlying cause of death on the death certificate were identified. Age-adjusted fatal stroke incidence for Whites, African Americans, American Indians, and Asian and Pacific Islanders aged 25 and older based on the U.S. Census of 2000 were calculated. The stroke rate ratio with 95% confidence interval (CI) and average annual percentage change over 10 years was also calculated.

Results RESULTS: From 2000-2009, the U.S. age-adjusted annual death rate per 100,000 for stroke was 242 in African Americans and 199 in whites. The difference between rates in African Americans and whites ranged from 2 excessive deaths per 100,000 in persons aged 25-34 years to 82 excessive deaths per 100,000 in persons aged 75-84 years. Compared with whites, the stroke rate ratio was 1.2(95% CI 1.0-1.3) for African Americans, 0.6(95% CI 0.5-0.8) for American Indians, and 0.8(95% CI 0.7-1.0) for Asian and Pacific Islanders. The average annual percentage change over 10 years was -6.1%, -5.3%, -5.2%, and -4.6% Asian and Pacific Islanders, American Indians, whites, and African Americans, respectively.

Conclusions CONCLUSIONS: There has been a similar reduction in stroke related mortality among all racial groups between 2000 and 2009. However, the excessive stroke mortality among African Americans continues and is unlikely to change without primary and secondary preventive strategies targeted towards African Americans.

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Ameer Hassan, DO (Valley Baptist Medical Center)	Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
John T. Kissel, MD, FAAN	Dr. Kissel has nothing to disclose.
Hamza I. Maqsood, MD (Dept of Neurology)	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.

��ɫ��

��ɫ��